By Colin Kellaher
Amgen on Thursday unveiled plans to spend $1 billion on a second drug-substance manufacturing plant in Holly Springs, N.C., boosting its total planned investment in the town to more than $1.5 billion.
The Thousand Oaks, Calif., biotechnology company, which in 2022 broke ground on a $550 million manufacturing plant in Holly Springs, said its investments will create 370 new jobs in the region.
Amgen said the expansion is part of efforts to meet growing demand for its therapies.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
December 05, 2024 09:31 ET (14:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.